ATE277080T1 - Verfahren zur herstellung von pth- und ptrp- analogen verbindungen - Google Patents

Verfahren zur herstellung von pth- und ptrp- analogen verbindungen

Info

Publication number
ATE277080T1
ATE277080T1 AT97112595T AT97112595T ATE277080T1 AT E277080 T1 ATE277080 T1 AT E277080T1 AT 97112595 T AT97112595 T AT 97112595T AT 97112595 T AT97112595 T AT 97112595T AT E277080 T1 ATE277080 T1 AT E277080T1
Authority
AT
Austria
Prior art keywords
ptrp
analogue compounds
pth
producing
producing pth
Prior art date
Application number
AT97112595T
Other languages
English (en)
Inventor
Humberto Bartolome Arzeno
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE277080T1 publication Critical patent/ATE277080T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/635Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/10Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/18Drugs for disorders of the endocrine system of the parathyroid hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
    • C07K1/026General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution by fragment condensation in solution
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C07K1/061General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT97112595T 1996-07-30 1997-07-23 Verfahren zur herstellung von pth- und ptrp- analogen verbindungen ATE277080T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2332296P 1996-07-30 1996-07-30

Publications (1)

Publication Number Publication Date
ATE277080T1 true ATE277080T1 (de) 2004-10-15

Family

ID=21814418

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97112595T ATE277080T1 (de) 1996-07-30 1997-07-23 Verfahren zur herstellung von pth- und ptrp- analogen verbindungen

Country Status (30)

Country Link
US (1) US6849710B1 (de)
EP (1) EP0822200B1 (de)
JP (1) JP4229992B2 (de)
KR (1) KR100518982B1 (de)
CN (1) CN1293096C (de)
AR (2) AR008094A1 (de)
AT (1) ATE277080T1 (de)
AU (1) AU731160B2 (de)
BR (1) BR9704138A (de)
CA (1) CA2206008C (de)
CO (1) CO4650046A1 (de)
CZ (1) CZ239697A3 (de)
DE (1) DE69730787T2 (de)
DK (1) DK0822200T3 (de)
ES (1) ES2227639T3 (de)
HR (1) HRP970416A2 (de)
HU (1) HUP9701277A3 (de)
IL (1) IL121391A0 (de)
MA (1) MA24353A1 (de)
MX (1) MX9705719A (de)
NO (1) NO973482L (de)
NZ (1) NZ328411A (de)
PE (1) PE91998A1 (de)
PL (1) PL321391A1 (de)
SG (1) SG67408A1 (de)
TR (1) TR199700714A2 (de)
TW (1) TW505654B (de)
UY (1) UY24651A1 (de)
YU (1) YU32197A (de)
ZA (1) ZA976555B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04006728A (es) 2002-01-10 2005-08-19 Osteotrophin Llc Tratamiento de desordenes oseos con medicamentos anabolicos esqueleticos.
US7378495B2 (en) * 2002-10-21 2008-05-27 Pevion Biotech, Ltd. PTH-rP related peptide cancer therapeutics
CA2628945A1 (en) * 2005-11-10 2007-05-24 Board Of Control Of Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
WO2007082890A1 (en) * 2006-01-17 2007-07-26 N.V. Organon SELECTIVE ENZYMATIC HYDROLYSIS OF C-TERMINAL tert-BUTYL ESTERS OF PEPTIDES
KR20170067906A (ko) 2006-10-03 2017-06-16 라디우스 헬쓰, 인코포레이티드 골 아나볼릭 단백질을 위한 약물 전달 방법
USRE49444E1 (en) 2006-10-03 2023-03-07 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
US7803770B2 (en) 2006-10-03 2010-09-28 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
US8563513B2 (en) 2009-03-27 2013-10-22 Van Andel Research Institute Parathyroid hormone peptides and parathyroid hormone-related protein peptides and methods of use
JP2013512688A (ja) 2009-12-07 2013-04-18 ミシガン テクノロジカル ユニバーシティ クロクマの副甲状腺ホルモン及びクロクマの副甲状腺ホルモンを使用する方法
CN102731643A (zh) * 2012-06-26 2012-10-17 深圳翰宇药业股份有限公司 一种治疗骨质疏松多肽的制备方法
CN102993293B (zh) * 2012-12-05 2014-05-07 深圳翰宇药业股份有限公司 一种特立帕肽醋酸盐的纯化方法
ES2624961T3 (es) 2013-03-21 2017-07-18 Sanofi-Aventis Deutschland Gmbh Síntesis de productos de péptido que contienen imida cíclica
AU2014234400B2 (en) 2013-03-21 2017-11-16 Sanofi-Aventis Deutschland Gmbh Synthesis of hydantoin containing peptide products
CN104530198B (zh) * 2014-12-09 2017-09-15 兰州大学 一种片段缩合制备醋酸去氨加压素的方法
IL255148B2 (en) 2015-04-29 2023-04-01 Radius Pharmaceuticals Inc 1901 rad for use in a method to inhibit a cancerous growth or induce tumor regression in a patient who is resistant to the drug and/or has cancer positive for an estrogen receptor alpha mutation
CN117417263A (zh) 2017-01-05 2024-01-19 雷迪厄斯制药公司 Rad1901-2hcl的多晶型形式
US10996208B2 (en) 2017-04-28 2021-05-04 Radius Health, Inc. Abaloparatide formulations and methods of testing, storing, modifying, and using same
WO2019175173A1 (en) * 2018-03-12 2019-09-19 Fresenius Kabi Ipsum S.R.L. Process for the manufacture of pthrp analogue
CN112423844A (zh) 2018-07-04 2021-02-26 雷迪厄斯制药公司 Rad1901-2hcl的多晶型形式
CN111057139B (zh) * 2018-10-17 2023-12-22 南京华威医药科技集团有限公司 一种制备特立帕肽的新工艺

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3886132A (en) * 1972-12-21 1975-05-27 Us Health Human parathyroid hormone
FR2550204B1 (fr) * 1983-08-05 1987-11-13 Toyo Jozo Kk Derives peptidiques de (nle8,nle1b, tyr34)-h-pth
WO1992000753A1 (en) * 1990-07-13 1992-01-23 The Regents Of The University Of California PARATHYROID HORMONE ANALOGUES MODIFIED AT POSITIONS 3, 6 or 9
GB9020544D0 (en) * 1990-09-20 1990-10-31 Sandoz Ltd Improvements in or relating to organic compounds
US5589452A (en) * 1992-07-14 1996-12-31 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
CN1070500C (zh) * 1993-07-13 2001-09-05 森德克斯(美国)股份有限公司 甲状旁腺激素类似物和甲状旁腺激素相关肽:合成和治疗骨质疏松症的用途
CO4410206A1 (es) * 1994-07-28 1997-01-09 Sandoz Ag DERIVADOS DE PTH o PTHrP, SU PREPARACION Y COMPOSICIONES FARMACEUTICAS QUE LAS COMPRENDEN

Also Published As

Publication number Publication date
DE69730787D1 (de) 2004-10-28
MA24353A1 (fr) 1998-07-01
HUP9701277A3 (en) 2001-02-28
ZA976555B (en) 1998-01-30
EP0822200B1 (de) 2004-09-22
DE69730787T2 (de) 2005-10-13
NO973482D0 (no) 1997-07-29
UY24651A1 (es) 2000-12-29
HRP970416A2 (en) 1998-08-31
PL321391A1 (en) 1998-02-02
CZ239697A3 (cs) 1998-04-15
CN1293096C (zh) 2007-01-03
BR9704138A (pt) 1998-12-29
KR100518982B1 (ko) 2006-05-29
CN1174845A (zh) 1998-03-04
HU9701277D0 (en) 1997-09-29
EP0822200A1 (de) 1998-02-04
ES2227639T3 (es) 2005-04-01
JP4229992B2 (ja) 2009-02-25
NO973482L (no) 1998-02-02
NZ328411A (en) 1998-12-23
HUP9701277A2 (hu) 1998-11-30
YU32197A (sh) 1999-07-28
SG67408A1 (en) 1999-09-21
AU3236297A (en) 1998-02-05
JPH1077295A (ja) 1998-03-24
TW505654B (en) 2002-10-11
CA2206008C (en) 2008-09-23
CO4650046A1 (es) 1998-09-03
DK0822200T3 (da) 2005-01-31
TR199700714A2 (xx) 1998-02-21
AR008094A1 (es) 1999-12-09
MX9705719A (es) 1998-02-28
PE91998A1 (es) 1998-12-31
CA2206008A1 (en) 1998-01-30
US6849710B1 (en) 2005-02-01
AU731160B2 (en) 2001-03-22
IL121391A0 (en) 1998-01-04
AR016981A2 (es) 2001-08-01
KR980009282A (ko) 1998-04-30

Similar Documents

Publication Publication Date Title
ATE277080T1 (de) Verfahren zur herstellung von pth- und ptrp- analogen verbindungen
DE59708146D1 (de) Verfahren zur herstellung von polyalkoholen
ATE243211T1 (de) Verfahren zur herstellung von dihalogenazolopyrimidinen
DE69618020D1 (de) Verfahren zur herstellung von hydrofluorethern
DE69519379D1 (de) Verfahren zur herstellung von trifluorethylene
DE69818485D1 (de) Verfahren zur herstellung von elektronischen bauteilen
ATE194850T1 (de) Verfahren zur herstellung von peroxiperfluoropolyxyalkylene
DE59705109D1 (de) Verfahren zur herstellung von arylcyanaten
DE59305905D1 (de) Verfahren zur herstellung von n-alkanoyl-polyhydroxyalkylaminen
DE69510466D1 (de) Verfahren zur herstellung von n-phosphonomethylglyzin
DE69327650D1 (de) Verfahren zur herstellung von chlordioxid
DE69709702D1 (de) Verfahren zur herstellung von diketonverbindungen
DE59401406D1 (de) Verfahren zur herstellung von naphtalocyaninen
ATE198318T1 (de) Verfahren zur herstellung von n-acetonylbenzamide
DE69512429D1 (de) Verfahren zur herstellung von polyoxymethylen
DE59704683D1 (de) Verfahren zur herstellung von 6-aminocapronitril
DE59509620D1 (de) Verfahren zur herstellung von acyloinen
DE69813596D1 (de) Verbindungen und verfahren zur herstellung substituierter 4-phenyl-4-cyanocyclohexansäuren
DE69514369D1 (de) Verfahren zur herstellung von pentafluorethan
DE59404478D1 (de) Verfahren zur herstellung von polyvinylpyridin-n-oxiden
ATE221056T1 (de) Verfahren zur herstellung von benzisothiazolin-3- onen
DE69318307D1 (de) Verfahren zur herstellung von difluormethan
DE69418472D1 (de) Verfahren zur herstellung von goethit
ATE200675T1 (de) Verfahren zur herstellung von imidazodiazepinderivaten
DE59704682D1 (de) Verfahren zur herstellung von 6-aminocapronitril

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0822200

Country of ref document: EP